GuidelineACRCT / MRILiver Structured report

LI-RADS Treatment Response

ACR · v2024 · 2024

Post-locoregional treatment response of HCC: LR-TR Nonviable, Equivocal, Viable — applies to ablation, TACE, TARE.

Applies to

CT / MRI

Does NOT apply to

Modality

CT / MRI

Evidence

Society consensus

30-second summary

Post-locoregional treatment response of HCC: LR-TR Nonviable, Equivocal, Viable — applies to ablation, TACE, TARE.